DK1383897T3 - Selv-containing Lactococcus-stamme - Google Patents

Selv-containing Lactococcus-stamme

Info

Publication number
DK1383897T3
DK1383897T3 DK02740565T DK02740565T DK1383897T3 DK 1383897 T3 DK1383897 T3 DK 1383897T3 DK 02740565 T DK02740565 T DK 02740565T DK 02740565 T DK02740565 T DK 02740565T DK 1383897 T3 DK1383897 T3 DK 1383897T3
Authority
DK
Denmark
Prior art keywords
self
survive
lactococcus strain
medium
containing lactococcus
Prior art date
Application number
DK02740565T
Other languages
Danish (da)
English (en)
Inventor
Lothar Steidler
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of DK1383897T3 publication Critical patent/DK1383897T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/01—Methyltransferases (2.1.1)
    • C12Y201/01045—Thymidylate synthase (2.1.1.45)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK02740565T 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme DK1383897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201631 2001-05-03
EP01204785 2001-12-07

Publications (1)

Publication Number Publication Date
DK1383897T3 true DK1383897T3 (da) 2006-10-30

Family

ID=26076897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740565T DK1383897T3 (da) 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme

Country Status (9)

Country Link
EP (1) EP1383897B1 (https=)
JP (2) JP4347575B2 (https=)
AT (1) ATE331789T1 (https=)
AU (1) AU2002314040B2 (https=)
CA (1) CA2446776C (https=)
DE (1) DE60212825T2 (https=)
DK (1) DK1383897T3 (https=)
ES (1) ES2266515T3 (https=)
WO (1) WO2002090551A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
AU2003303222A1 (en) * 2002-12-19 2004-07-14 Universiteit Gent Mutant proteins showing increased secretion
JP4589618B2 (ja) 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
US9200249B2 (en) 2004-08-20 2015-12-01 Actogenix N.V. Method to improve Lactococcus preservation
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
AU2008204442B2 (en) * 2007-01-12 2013-03-14 Intrexon Actobiotics Nv Lactococcus promoters and uses thereof
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
EP3181682B1 (en) * 2008-09-29 2021-04-21 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
WO2012164083A1 (en) 2011-06-01 2012-12-06 Actogenix N.V. Polycistronic expression system for bacteria
HUE038336T2 (hu) 2011-09-23 2018-10-29 Intrexon Actobiotics Nv Módosított gram-pozitív baktériumok és alkalmazásaik
JP6117212B2 (ja) 2011-09-23 2017-04-19 イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ 改変されたグラム陽性菌及びその使用
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
JP7095993B2 (ja) * 2015-03-02 2022-07-05 シンロジック オペレーティング カンパニー インコーポレイテッド 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
ES2881384T3 (es) 2015-05-13 2021-11-29 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
ES2925049T3 (es) 2015-11-16 2022-10-13 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
US10905727B2 (en) 2016-01-14 2021-02-02 Intrexon Actobiotics N.V. Compositions and methods for the treatment of type 1 diabetes
CN118813511A (zh) 2016-09-02 2024-10-22 英特瑞克斯顿阿克图比奥帝克斯有限公司 稳定表达il-10和胰岛素的遗传修饰的细菌
RU2021135949A (ru) 2016-09-13 2022-04-14 Интрексон Актобиотикс Н.В. Мукоадгезивный микроорганизм
CN111655841A (zh) 2017-06-21 2020-09-11 同生运营公司 用于治疗紊乱的细菌
WO2020075171A1 (en) 2018-10-11 2020-04-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Bacteria expressing single chain antibodies against toll-like receptors
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Also Published As

Publication number Publication date
AU2002314040B2 (en) 2007-06-28
ATE331789T1 (de) 2006-07-15
WO2002090551A3 (en) 2003-03-27
DE60212825D1 (de) 2006-08-10
DE60212825T2 (de) 2007-01-11
JP2004533246A (ja) 2004-11-04
EP1383897B1 (en) 2006-06-28
JP4347575B2 (ja) 2009-10-21
JP2009060913A (ja) 2009-03-26
WO2002090551A2 (en) 2002-11-14
CA2446776C (en) 2011-07-12
EP1383897A2 (en) 2004-01-28
CA2446776A1 (en) 2002-11-14
ES2266515T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
DK1383897T3 (da) Selv-containing Lactococcus-stamme
WO2004046346A3 (en) Self-containing lactobacillus strain
ATE476439T1 (de) Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)
MXPA03005960A (es) Nuevas mezclas de enzimas microbianas.
GEP20012471B (en) Inhibitors of Serine Proteases, Particularly Hepatitis C Virus NS3 Protease
EA200870619A1 (ru) Модифицированный фермент дикамба-монооксигеназа и способы его применения
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
GB2403358B (en) Digital pre-distortion for the linearizazion of power amplifiers with asymetrical characteristics
EP1678315A4 (en) ZINC FINGER PROTEINS FROM GENETIC GENE FOR REGULATING GENE EXPRESSION
ATE341606T1 (de) Natriumpercarbonatpartikel mit verbesserter lagerstabilit t
ATE468627T1 (de) Disc-monopol-antennenstruktur
ITVA20020050A1 (it) Metodo e circuito di amplificazione con pre-enfasi.
DE60141141D1 (de) Mechanismus zur implementierung einer transparenten z-komprimierung
SG149058A1 (en) Live genetically attenuated malaria vaccine
TW200708929A (en) Opposite-phase scheme for peak current reduction
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
AU2003227457A1 (en) Comparison of source files
ITRM20020115A0 (it) Espressione di enzimi lisosomiali in seme.
AU2002302623A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
MXPA05005574A (es) Compuestos calciliticos.
AU2003255287A1 (en) Use of a proteasome inhibitor in the treatment of fibrotic diseases
DE60224026D1 (de) Rechen
AU302730S (en) Bed
DE60324285D1 (de) Immunmodulatorische konstrukte und deren verwendungen
ITMI20022273A1 (it) Sintesi enzimatica di (s)-1, 2-0-1, 2-0-isopropilidenglicerolo.